Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease.
about
Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography.Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy.Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis.Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II studyImpairment of diastolic function during short-term anthracycline chemotherapy.Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.Clinical Characteristics and Treatment of Cardiomyopathies in Children.Current views on anthracycline cardiotoxicity.Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.Myocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy.Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats.Drugs approved for the treatment of multiple sclerosis: review of their safety profile.Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis
P2860
Q28361151-6889C65E-17F8-4188-B189-6973E621E031Q30491590-4E13A113-B3F6-4B67-9C44-026D6A1F816BQ33985488-2BF67A47-A601-4118-B4C1-55E23717D6DDQ34102834-4CD8CF82-D0A4-4546-A2A4-BBFF5C08BF9BQ34535269-495754C6-FD53-4BA8-B539-2CF05C40BD37Q34659375-9959C1DA-1055-4F7B-A58D-105434483CD9Q35623306-568DD582-B0BD-41E0-B48C-8A67947DC548Q36611388-88888CE3-74BA-4D3E-9EA5-81824F348E6BQ36815419-AF6D79A2-CDBB-406B-830E-4C25F0C122C1Q36817729-54928FB7-7EEC-4792-8A66-4C94FF9B8028Q36886275-27E72554-6BE8-429E-B0B7-E0525CABE04BQ38845535-C2A16C93-69C4-4D3B-9E8F-E757457CF958Q40304250-B10BED78-0EA7-4A2A-82AC-26A5C136DE3BQ44391942-B2F3AC2F-079B-406B-B24D-29789774491FQ46930825-2F37CE58-5BBE-493B-8CBA-C4CCD3BEA996Q47868767-46C32FAC-3C00-454E-B814-F08985BD10ADQ56986554-F4FC2A45-675A-47DF-9588-9B2787FCCBB3
P2860
Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease.
description
1986 nî lūn-bûn
@nan
1986 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մարտին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@ast
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@en
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@nl
type
label
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@ast
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@en
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@nl
prefLabel
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@ast
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@en
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@nl
P2093
P2860
P356
P1476
Chronic anthracycline cardioto ...... ictive endomyocardial disease.
@en
P2093
Baandrup U
Mortensen SA
P2860
P304
P356
10.1136/HRT.55.3.274
P577
1986-03-01T00:00:00Z